MOA, clinical effects

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/7

encourage image

There's no tags or description

Looks like no tags are added yet.

8 Terms

1
New cards

Second Generation Histamine 1-Receptor Antagonist (H1RA)

Pharmacology: Competes with histamine for H1-receptor sites on effector cells in the gastrointestinal tract, blood vessels, and respiratory tract. Inhibits histamine induced effects on conjunctival epithelial cells. 

Clinical effects: Provides relief of eye, nasal, and skin discomfort due to allergies

2
New cards

First Generation Histamine 1-Receptor Antagonist (H1RA)

Pharmacology: Competes with histamine for H1-receptor sites on effector cells in the gastrointestinal tract, blood vessels, and respiratory tract. Possesses skeletal muscle relaxing, bronchodilator, antihistamine, antiemetic, and analgesic properties. Activity at muscarinic, serotonergic (5HT2), and dopaminergic receptors in the hippocampus, cerebral cortices, and whole brain may produce anxiolytic effects. 

Clinical Effects: Sedating antihistamines used to treat allergic conditions, motion sickness, sleep aid

  • Hydroxyzine also used for anxiety and itching

  • Meclizine mostly used for motion sickness or vertigo

  • Promethazine mostly used for motion sickness, vertigo, or N/V in pregnancy


3
New cards

Attitussive (benzonatate)

Pharmacology: Tetracaine congener with antitussive properties; anesthetic action on the respiratory stretch receptors 

Clinical Effect: Suppresses cough

4
New cards

Cough Suppressant (dextromethorphan)

Pharmacology: Serotonin reuptake inhibitor that depresses the medullary cough center through sigma receptor stimulation; structurally related to codeine

Clinical Effects: Suppresses cough reflex, can help with sleep when coughing + causes drowsiness


5
New cards

Expectorant (guaifenesin)

Pharmacology: Increases the effective hydration of the respiratory tract, maintains the sol layer needed for ciliary clearance and reduces the viscosity of respiratory mucus, thereby further facilitating its removal by natural clearance processes.

Clinical Effects: Helps loose phlegm and thin bronchial secretions (reduce viscosity of secretions)

6
New cards

Alpha-Adrenergic Agonist (phenylephrine)

Pharmacology: Direct-acting alpha-adrenergic agonist, resulting in vasoconstriction

Clinical Effects: Vasoconstriction causes a decrease in sinus engorgement, and then decrease in mucosal edema; these help decongest the nose. Vasoconstriction can also increase systemic vascular resistance, causing increases in blood pressure

7
New cards

Anaphylaxis Agent: Alpha/beta Agonist (epinephrine)

Pharmacology: Stimulates alpha-, beta1-, and beta2-adrenergic receptors resulting in relaxation of smooth muscle of the bronchial tree, cardiac stimulation (increasing myocardial oxygen consumption), and dilation of skeletal muscle vasculature; small doses can cause vasodilation via beta 2-vascular receptors; large doses may produce constriction of skeletal and vascular smooth muscle

Clinical Effects: Reduce mucosal edema in upper airway in anaphylaxis; Increase MAP in shock

8
New cards

Decongestant: Alpha/Beta Agonist (pseudoephedrine)

Pharmacology: Directly stimulates alpha-adrenergic receptors of respiratory mucosa causing vasoconstriction; directly stimulates beta-adrenergic receptors causing bronchial relaxation, increased heart rate and contractility

Clinical Effects: Vasoconstriction causes a decrease in sinus engorgement, and then decrease in mucosal edema; these help decongest the nose